OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.
企業コードOSUR
会社名OraSure Technologies Inc
上場日Nov 17, 1986
最高経営責任者「CEO」Eglinton Manner (Carrie)
従業員数501
証券種類Ordinary Share
決算期末Nov 17
本社所在地220 E First St
都市BETHLEHEM
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号18015
電話番号15036416115
ウェブサイトhttps://www.orasure.com/
企業コードOSUR
上場日Nov 17, 1986
最高経営責任者「CEO」Eglinton Manner (Carrie)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし